Teva Pharmaceutical Industries Limited (TLV:TEVA)
6,186.00
+211.00 (3.53%)
Feb 20, 2025, 5:24 PM IDT
Teva Pharmaceutical Industries Employees
As of December 31, 2024, Teva Pharmaceutical Industries had 35,686 total employees, including 33,892 full-time and 1,794 part-time employees. The number of employees decreased by 786 or -2.16% compared to the previous year.
Employees
35,686
Change (1Y)
-786
Growth (1Y)
-2.16%
Revenue / Employee
1.73M ILS
Profits / Employee
-171.60K ILS
Market Cap
68.37B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 35,686 | -786 | -2.16% |
Dec 31, 2023 | 36,472 | 1,347 | 3.83% |
Dec 31, 2022 | 35,125 | -854 | -2.37% |
Dec 31, 2021 | 35,979 | -2,393 | -6.24% |
Dec 31, 2020 | 38,372 | -1,667 | -4.16% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Related Stocks
Company Name | Employees |
---|---|
Danel (Adir Yeoshua) | 3,961 |
Kamada | 378 |
Bait Bakfar | 228 |
Novolog (Pharm-Up 1966) | 955 |
Ilex Medical | 223 |
BrainsWay | 134 |
SofWave Medical | 117 |
Golden House | 115 |
Teva Pharmaceutical Industries News
- 16 hours ago - Teva Pharmaceutical Industries Ltd (TEVA) Launches SELARSDI⢠in the U.S. - GuruFocus
- 1 day ago - Teva and Sanofi Present New Positive Phase 2b Study Results at ECCO 2025 Reinforcing Best-in-Class Potential of Duvakitug (Anti-TL1A) in Ulcerative Colitis and Crohn's Disease - GlobeNewsWire
- 1 day ago - Final Trade: TEVA, JNJ, TJX, BABA - CNBC
- 2 days ago - Teva/Alvotech follow Amgen in launching biosimilar for J&J’s Stelara - Seeking Alpha
- 2 days ago - Teva Pharma and Alvotech launch US biosimilar to J&J's Stelara - Reuters
- 2 days ago - Teva and Alvotech Announce SELARSDI™ (ustekinumab-aekn) Injection Now Available in the U.S. - GlobeNewsWire
- 2 days ago - Corcept accused in California of stifling Teva’s generic launch - Seeking Alpha
- 4 days ago - Teva Pharmaceutical Industries Ltd (TEVA) and Alvotech Announce FDA Review of Biosimilar Application - GuruFocus